WASHINGTON TRUST BANK Buys 3, Sells 2 in 4th Quarter

WASHINGTON TRUST BANK recently filed their 13F report for the fourth quarter of 2022, which ended on 2022-12-31.

The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.

POST OFFICE BOX 2127 SPOKANE, WA 99210-2127

As of the latest 13F report, the guru’s equity portfolio contained 221 stocks valued at a total of $882.00Mil. The top holdings were SCZ(9.66%), PCAR(5.71%), and PG(4.23%).

According to GuruFocus data, these were WASHINGTON TRUST BANK’s top five trades of the quarter.

iShares MSCI EAFE Small-Cap ETF


During the quarter, WASHINGTON TRUST BANK bought 648,711 shares of NAS:SCZ for a total holding of 1,507,724. The trade had a 4.16% impact on the equity portfolio. During the quarter, the stock traded for an average price of $53.68.

On 02/07/2023, iShares MSCI EAFE Small-Cap ETF traded for a price of $60.48 per share and a market cap of $11.53Bil. The stock has returned -10.48% over the past year.

There is insufficient data to calculate the stock’s financial strength and profitability ratings.

In terms of valuation, iShares MSCI EAFE Small-Cap ETF has a price-earnings ratio of 11.18 and a price-book ratio of 1.26.

iShares Barclays GNMA Bond Fund


The guru sold out of their 332,565-share investment in NAS:GNMA. Previously, the stock had a 1.82% weight in the equity portfolio. Shares traded for an average price of $43.08 during the quarter.

On 02/07/2023, iShares Barclays GNMA Bond Fund traded for a price of $44.45 per share and a market cap of $411.52Mil. The stock has returned -6.92% over the past year.

There is insufficient data to calculate the stock’s financial strength and profitability ratings.

iShares Russell 1000 Growth ETF


During the quarter, WASHINGTON TRUST BANK bought 57,263 shares of ARCA:IWF for a total holding of 67,173. The trade had a 1.39% impact on the equity portfolio. During the quarter, the stock traded for an average price of $219.59.

On 02/07/2023, iShares Russell 1000 Growth ETF traded for a price of $236.74 per share and a market cap of $61.37Bil. The stock has returned -13.54% over the past year.

There is insufficient data to calculate the stock’s financial strength and profitability ratings.

In terms of valuation, iShares Russell 1000 Growth ETF has a price-earnings ratio of 25.72 and a price-book ratio of 8.64.

Thermo Fisher Scientific Inc


WASHINGTON TRUST BANK reduced their investment in NYSE:TMO by 20,627 shares. The trade had a 1.33% impact on the equity portfolio. During the quarter, the stock traded for an average price of $529.89.

On 02/07/2023, Thermo Fisher Scientific Inc traded for a price of $576.17 per share and a market cap of $225.97Bil. The stock has returned -2.91% over the past year.

GuruFocus gives the company a financial strength rating of 6 out of 10 and a profitability rating of 9 out of 10.

In terms of valuation, Thermo Fisher Scientific Inc has a price-earnings ratio of 42.30, a price-book ratio of 5.13, a price-earnings-to-growth (PEG) ratio of 1.99, a EV-to-Ebitda ratio of 21.48 and a price-sales ratio of 5.02.

The price-to-GF Value ratio is 0.89, earning the stock a GF Value rank of 7.

Merck & Co Inc


During the quarter, WASHINGTON TRUST BANK bought 103,896 shares of NYSE:MRK for a total holding of 125,592. The trade had a 1.31% impact on the equity portfolio. During the quarter, the stock traded for an average price of $102.22.

On 02/07/2023, Merck & Co Inc traded for a price of $104.03 per share and a market cap of $263.76Bil. The stock has returned 36.11% over the past year.

GuruFocus gives the company a financial strength rating of 7 out of 10 and a profitability rating of 8 out of 10.

In terms of valuation, Merck & Co Inc has a price-earnings ratio of 18.22, a price-book ratio of 5.93, a price-earnings-to-growth (PEG) ratio of 2.40, a EV-to-Ebitda ratio of 13.90 and a price-sales ratio of 4.48.

The price-to-GF Value ratio is 0.98, earning the stock a GF Value rank of 6.


Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.

When GuruFocus covers insider information, we only track open market or the private purchase and sale of common stock with the transaction code of P or S. Therefore, all the transactions mentioned in this article are only the ones with transaction code of P or S.

Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!

This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.